Start-up
LimmaTech Biologics AG
About LimmaTech Biologics
LimmaTech Biologics AG is a Swiss clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antimicrobial resistance (AMR) and sexually transmitted diseases.
LimmaTech was founded in 2015 as a spin-off from GlycoVaxyn.
Facts about LimmaTech Biologics
Facts about LimmaTech Biologics
- Founding: 2015
- Focus : Service
- Employees: 11-50
- Industry : Biotechnology
